Abstract | INTRODUCTION:
Dyspnea is prominently observed in palliative care (PC). Dyspnea can be multifactorial, primarily caused by obstructive or restrictive lung diseases or secondarily induced by various comorbidities. Numerous interventions exist, with route of administration and efficacy requiring further discussion. Despite opioids being the first line of treatment, their adverse effects lead to reluctance on the side of patients to take them, creating limitations in patient management planning. OBJECTIVES: This paper reviews and highlights the role of inhalers for dyspnea management in PC. METHODS: The CINAHL, CENTRAL, and OVID databases were searched for scholarly articles on the role of inhalers in dyspnea management from 1998 to the present. A grey literature Internet search was also performed via Google, the World Health Organization, and CareSearch. Twenty-five articles relevant to the subject at hand were located and summarized. The Cochrane Systematic Reviews of Health Promotion and Public Health Interventions Handbook was consulted for structuring. RESULT: CONCLUSION:
|
Authors | Helen Senderovich, Akash Yendamuri |
Journal | Rambam Maimonides medical journal
(Rambam Maimonides Med J)
Vol. 10
Issue 1
(Jan 28 2019)
ISSN: 2076-9172 [Print] Israel |
PMID | 30332384
(Publication Type: Journal Article, Review)
|